Yunfei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yunfei Zhang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Yongming Dai
School of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai, China
2 shared publications - Caili Tang
Department of Radiology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
1 shared publication Donglin Bian
Department of Ultrasonic Diagnosis, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
1 shared publicationFeihang Wang
Central Research Institute United Imaging Healthcare Shanghai China
1 shared publication- Jing Han
Department of Pathology, Zhongshan Hospital Fudan University Shanghai China
1 shared publication - Jingru Yi
Department of Radiology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
1 shared publication
Latest Publications
- 8 December 2022
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 58 (2) , 392-402
Assessment of an MR Elastography‐Based Nomogram as a Potential Imaging Biomarker for Predicting Microvascular Invasion of Hepatocellular Carcinoma
Background: Microvascular invasion (MVI) is a well‐established poor prognostic factor for hepatocellular carcinoma (HCC). Preoperative prediction of MVI is important for both therapeutic and prognostic purposes, but noninvasive methods are lacking.Purpose: To develop an MR elastography (MRE)‐based nomogram for the preoperative prediction of MVI in HCC.Study Type: Prospective.Subjects: A total of 111 patients with surgically resected single HCC (52 MVI‐positive and 59 MVI‐negative), randomly allocated to training and validation cohorts (7:3 ratio).Field Strength/Sequence: 2D‐MRE and conventional sequences (T1‐weighted in‐phase and opposed phase gradient echo, T2‐weighted fast spin echo, diffusion‐weighted single‐shot spin echo echo‐planar, and dynamic contrast‐enhanced T1‐weighted gradient echo) at 3.0 T.Assessment: MRE‐stiffness and conventional qualitative and quantitative MRI features were evaluated and compared between MVI‐positive and MVI‐negative HCCs.Statistical Tests: Univariable and multivariable logistic regression analyses were applied to identify potential predictors for MVI, and a nomogram was constructed according to the predictive model. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance. Harrell's C‐index evaluated the discrimination performance of the nomogram, calibration curves analyzed its diagnostic performance and decision curve analysis determined its clinical usefulness. A P value 6.284 kPa (odds ratio [OR] = 24.38) and the presence of arterial peritumoral enhancement (OR = 6.36) were independent variables associated with MVI. The areas under the ROC curves for tumor stiffness were 0.81 (95% confidence interval [CI]: 0.70, 0.89) and 0.77 (95% CI: 0.60, 0.90) in the training and validation cohorts, respectively. When both predictive variables were integrated, the best nomogram performance was achieved with C‐indices of 0.88 (95% CI: 0.78, 0.94) and 0.87 (95% CI: 0.71, 0.96) in the two cohorts, fitting well in calibration curves. The decision curve exhibited optimal net benefit with a wide range of threshold probabilities for the nomogram.Data Conclusion: An MRE‐based nomogram may be a potential noninvasive imaging biomarker for predicting MVI of HCC preoperatively.Evidence Level: 2.Technical Efficacy: Stage 2.
- 8 December 2022
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 58 (2) , 392-402
Assessment of an MR Elastography‐Based Nomogram as a Potential Imaging Biomarker for Predicting Microvascular Invasion of Hepatocellular Carcinoma
Background: Microvascular invasion (MVI) is a well‐established poor prognostic factor for hepatocellular carcinoma (HCC). Preoperative prediction of MVI is important for both therapeutic and prognostic purposes, but noninvasive methods are lacking.Purpose: To develop an MR elastography (MRE)‐based nomogram for the preoperative prediction of MVI in HCC.Study Type: Prospective.Subjects: A total of 111 patients with surgically resected single HCC (52 MVI‐positive and 59 MVI‐negative), randomly allocated to training and validation cohorts (7:3 ratio).Field Strength/Sequence: 2D‐MRE and conventional sequences (T1‐weighted in‐phase and opposed phase gradient echo, T2‐weighted fast spin echo, diffusion‐weighted single‐shot spin echo echo‐planar, and dynamic contrast‐enhanced T1‐weighted gradient echo) at 3.0 T.Assessment: MRE‐stiffness and conventional qualitative and quantitative MRI features were evaluated and compared between MVI‐positive and MVI‐negative HCCs.Statistical Tests: Univariable and multivariable logistic regression analyses were applied to identify potential predictors for MVI, and a nomogram was constructed according to the predictive model. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance. Harrell's C‐index evaluated the discrimination performance of the nomogram, calibration curves analyzed its diagnostic performance and decision curve analysis determined its clinical usefulness. A P value 6.284 kPa (odds ratio [OR] = 24.38) and the presence of arterial peritumoral enhancement (OR = 6.36) were independent variables associated with MVI. The areas under the ROC curves for tumor stiffness were 0.81 (95% confidence interval [CI]: 0.70, 0.89) and 0.77 (95% CI: 0.60, 0.90) in the training and validation cohorts, respectively. When both predictive variables were integrated, the best nomogram performance was achieved with C‐indices of 0.88 (95% CI: 0.78, 0.94) and 0.87 (95% CI: 0.71, 0.96) in the two cohorts, fitting well in calibration curves. The decision curve exhibited optimal net benefit with a wide range of threshold probabilities for the nomogram.Data Conclusion: An MRE‐based nomogram may be a potential noninvasive imaging biomarker for predicting MVI of HCC preoperatively.Evidence Level: 2.Technical Efficacy: Stage 2.
- 7 October 2022
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 57 (6) , 1832-1841
Quantitative Assessment of Restriction Spectrum MR Imaging for the Diagnosis of Breast Cancer and Association With Prognostic Factors
Background: Restriction spectrum imaging (RSI) is an advanced quantitative diffusion‐weighted magnetic resonance imaging (DWI) technique to assess breast cancer.Purpose: To investigate the ability of RSI to differentiate the benign and malignant breast lesions and the association with prognostic factors of breast cancer.Study Type: Retrospective.Population: Seventy women (mean age, 49.6 ± 12.3 years) with 56 malignant and 19 benign breast lesions.Field Strength/Sequence: 3‐T; RSI‐based DWI sequence with echo‐planar imaging technique.Assessment: The apparent diffusion coefficient (ADC) and RSI parameters (restricted diffusion f1, hindered diffusion f2, free diffusion f3, and signal fractions f1f2) were calculated by two readers for the whole lesion volume and compared between the benign and malignant groups and the subgroups with different statuses of prognostic factors in breast cancer.Statistical Tests: Mann–Whitney U test or Student's t‐test was applied to compare the quantitative parameters between the different groups. Intraclass correlation coefficient (ICC) was used to assess readers' reproducibility. Binary logistic regression was used to combine parameters. Area under the curve (AUC) of receiver operating characteristic curve analysis was used to evaluate the diagnostic performance of parameters to distinguish benign from malignant breast lesions. A P‐value f3 values, and significantly higher f1 and f1f2 values than the benign lesions, with AUC of 0.951, 0.877, 0.868, and 0.860, respectively. When RSI‐derived parameters and ADC were combined, the diagnostic performance was superior to either single parameter (AUC = 0.973). The f3 value was significantly differed between estrogen receptor (ER)‐positive and ER‐negative tumors. The ADC, f1, f3, and f1f2 values were significantly different progesterone receptor (PR)‐positive and PR‐negative status.Data Conclusion: The RSI‐derived parameters (f1, f3, and f1f2) may facilitate the differential diagnosis between benign and malignant breast lesions.Level of Evidence: 4Technical Efficacy: Stage 2
- 7 October 2022
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 57 (6) , 1832-1841
Quantitative Assessment of Restriction Spectrum MR Imaging for the Diagnosis of Breast Cancer and Association With Prognostic Factors
Background: Restriction spectrum imaging (RSI) is an advanced quantitative diffusion‐weighted magnetic resonance imaging (DWI) technique to assess breast cancer.Purpose: To investigate the ability of RSI to differentiate the benign and malignant breast lesions and the association with prognostic factors of breast cancer.Study Type: Retrospective.Population: Seventy women (mean age, 49.6 ± 12.3 years) with 56 malignant and 19 benign breast lesions.Field Strength/Sequence: 3‐T; RSI‐based DWI sequence with echo‐planar imaging technique.Assessment: The apparent diffusion coefficient (ADC) and RSI parameters (restricted diffusion f1, hindered diffusion f2, free diffusion f3, and signal fractions f1f2) were calculated by two readers for the whole lesion volume and compared between the benign and malignant groups and the subgroups with different statuses of prognostic factors in breast cancer.Statistical Tests: Mann–Whitney U test or Student's t‐test was applied to compare the quantitative parameters between the different groups. Intraclass correlation coefficient (ICC) was used to assess readers' reproducibility. Binary logistic regression was used to combine parameters. Area under the curve (AUC) of receiver operating characteristic curve analysis was used to evaluate the diagnostic performance of parameters to distinguish benign from malignant breast lesions. A P‐value f3 values, and significantly higher f1 and f1f2 values than the benign lesions, with AUC of 0.951, 0.877, 0.868, and 0.860, respectively. When RSI‐derived parameters and ADC were combined, the diagnostic performance was superior to either single parameter (AUC = 0.973). The f3 value was significantly differed between estrogen receptor (ER)‐positive and ER‐negative tumors. The ADC, f1, f3, and f1f2 values were significantly different progesterone receptor (PR)‐positive and PR‐negative status.Data Conclusion: The RSI‐derived parameters (f1, f3, and f1f2) may facilitate the differential diagnosis between benign and malignant breast lesions.Level of Evidence: 4Technical Efficacy: Stage 2
- Open Access
- 22 October 2020
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 20 (6) , 1
Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma
In the present study, the recurrence rate of papillary thyroid microcarcinoma (PTMC) was assessed by analyzing postoperative follow‑up data of affected patients and its associations with BRAF V600E, clinical pathology and imaging factors were explored. A total of 506 patients with PTMC were selected who underwent surgery from January 2014 to March 2016. The maximal diameter of thyroid nodules was ≤1 cm and all patients who underwent BRAF V600E testing and evaluation for lymph node metastasis. Postoperatively, each patient was regularly followed up to detect recurrence. Categorical variables were comparatively analyzed using univariate Cox linear regression analysis to screen for protective and adverse factors influencing recurrence of PTMC. A stepwise Cox proportional hazards regression model analysis was performed to explore risk factors affecting recurrence. Among the 506 patients, 477 were followed up, 29 were lost to follow‑up and 26 patients experienced recurrence. The 5‑year recurrent rate of PTMC was 5.45%. The univariate Cox regression analysis indicated that PTMC recurrence was influenced by BRAF V600E, sex, multifocality, capsular invasion and lateral cervical lymph node metastasis (P0.05). The significant factors associated with recurrent PTMC were subjected to stepwise multivariate Cox proportional hazards regression model analysis and the results indicated that BRAF V600E, sex, multifocality and lateral cervical lymph node metastasis were independent factors influencing recurrence in patients with PTMC, with a statistically significant difference (P<0.05). In conclusion, BRAF V600E, sex, multifocality and lateral cervical lymph node metastasis are independent risk factors for recurrent PTMC.
- 22 October 2020
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 20 (6) , 1
Open AccessAssociations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma
In the present study, the recurrence rate of papillary thyroid microcarcinoma (PTMC) was assessed by analyzing postoperative follow‑up data of affected patients and its associations with BRAF V600E, clinical pathology and imaging factors were explored. A total of 506 patients with PTMC were selected who underwent surgery from January 2014 to March 2016. The maximal diameter of thyroid nodules was ≤1 cm and all patients who underwent BRAF V600E testing and evaluation for lymph node metastasis. Postoperatively, each patient was regularly followed up to detect recurrence. Categorical variables were comparatively analyzed using univariate Cox linear regression analysis to screen for protective and adverse factors influencing recurrence of PTMC. A stepwise Cox proportional hazards regression model analysis was performed to explore risk factors affecting recurrence. Among the 506 patients, 477 were followed up, 29 were lost to follow‑up and 26 patients experienced recurrence. The 5‑year recurrent rate of PTMC was 5.45%. The univariate Cox regression analysis indicated that PTMC recurrence was influenced by BRAF V600E, sex, multifocality, capsular invasion and lateral cervical lymph node metastasis (P0.05). The significant factors associated with recurrent PTMC were subjected to stepwise multivariate Cox proportional hazards regression model analysis and the results indicated that BRAF V600E, sex, multifocality and lateral cervical lymph node metastasis were independent factors influencing recurrence in patients with PTMC, with a statistically significant difference (P<0.05). In conclusion, BRAF V600E, sex, multifocality and lateral cervical lymph node metastasis are independent risk factors for recurrent PTMC.